SCHEMBL24412628

SCHEMBL24412628

O=C(CCN(C1CCCCC1)C1CCCCC1)NCCCCCCCCCCCCCCCCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 7/20 0.50
▸ NAAA Q02083 2/20 0.41
▸ THRA P10827 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ HDAC3 O15379 1/20 0.38
▸ HDAC4 P56524 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ HDAC7 Q8WUI4 1/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ HDAC10 Q969S8 1/20 0.38
▸ HDAC11 Q96DB2 1/20 0.38
▸ HDAC8 Q9BY41 1/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.38
▸ HDAC9 Q9UKV0 1/20 0.38
▸ HDAC5 Q9UQL6 1/20 0.38
▸ DNM1 Q05193 1/20 0.38
▸ BCHE P06276 2/20 0.37
▸ ACHE P22303 2/20 0.37
▸ CASP2 P42575 1/20 0.37
▸ EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24412677 0.94 THRA (0.42) EPHX1NAAATHRATHRBHDAC3
SCHEMBL24412627 0.87 CASP2 (0.54) EPHX1NAAATHRATHRBDNM1
SCHEMBL24412691 0.79 BCHE (0.53) EPHX1NAAADNM1BCHEACHE
SCHEMBL24412938 0.75 CASP2 (0.54) EPHX1NAAADNM1CASP2EPHX2
SCHEMBL24444406 0.75 CASP2 (0.54) EPHX1NAAADNM1CASP2EPHX2
SCHEMBL24412733 0.75 CASP2 (0.54) EPHX1NAAADNM1CASP2EPHX2
SCHEMBL15285544 0.75 EPHX1 (0.37) EPHX1THRATHRB
SCHEMBL24412637 0.74 CASP2 (0.53) EPHX1NAAADNM1BCHEACHE
SCHEMBL9069176 0.71 ALDH1A1 (0.47) EPHX1THRATHRBEPHX2
SCHEMBL24014876 0.71 NAAA (0.61) EPHX1NAAADNM1CASP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220145045-A1 STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF SHAOXING RUIKANG BIOTECHNOLOGIES CO INC (CN) 2022-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220145045-A1 STRUCTURE OF ADJUSTABLE STERIC HINDRANCE WEAK BASIC LIGHT STABILIZER AND PREPARATION METHOD AND APPLICATION THEREOF PCNA, NCL, PNN EPHX1 3022/4885NAAA 172/4885THRA 3991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback